STAT

Opinion: What using animals for scientific research taught me about myself

When I looked for the deeper meaning of existence, I found that I was too skeptical for heaven and hell, for deities and spirits. Sometimes, I thought about astrophysics — roiling energy, dark matter, the multiple dimensions of an expanding universe — but it was all too vast and distant. The closest I ever got to a mystical experience was working with animals as a molecular biologist.

As a biologist, I performed experiments on flatworms, sea urchins, zebrafish, frogs, opossums, and mice. These studies required the careful administration of life and death: I merged sperm with eggs and observed early embryos when they were just three layers of tissues flattened together. At certain times, I preserved animals in formaldehyde and bathed them in chemicals that turned their bodies transparent.

In the lab, life and death were demythologized. Instead of some immense, cosmic force, they shrank into something tangible that could be contained in a Petri dish or studied under a microscope.

Read more: Coming to terms with six years in science: obsession, isolation, and moments of wonder

Watching generations of animals flash in and out of existence, I also felt time compressing. I cared for zebrafish embryos that, in a

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks